• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人体和鼠类精密切割肺切片中分离株的竞争适应性。

Competitive fitness of isolates in human and murine precision-cut lung slices.

机构信息

Clinical Research Group 'Pseudomonas Genomics', Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, Hannover Medical School, Hannover, Germany.

出版信息

Front Cell Infect Microbiol. 2022 Aug 23;12:992214. doi: 10.3389/fcimb.2022.992214. eCollection 2022.

DOI:10.3389/fcimb.2022.992214
PMID:36081773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9446154/
Abstract

Chronic respiratory infections with the gram-negative bacterium are an important co-morbidity for the quality of life and prognosis of people with cystic fibrosis (CF). Such long-term colonization, sometimes lasting up to several decades, represents a unique opportunity to investigate pathogen adaptation processes to the host. Our studies aimed to resolve if and to what extent the bacterial adaptation to the CF airways influences the fitness of the pathogen to grow and to persist in the lungs. Marker-free competitive fitness experiments of serial isolates differentiated by strain-specific SNPs, were performed with murine and human precision cut lung slices (PCLS). Serial isolates were selected from six mild and six severe CF patient courses, respectively. MPCLS or hPCLS were inoculated with a mixture of equal numbers of the serial isolates of one course. The temporal change of the composition of the bacterial community during competitive growth was quantified by multi-marker amplicon sequencing. Both models displayed a strong separation of fitness traits between mild and severe courses. Whereas the earlier isolates dominated the competition in the severe courses, intermediate and late isolates commonly won the competition in the mild courses. The status of the CF lung disease rather than the bacterial genotype drives the adaptation of during chronic CF lung infection. This implies that the disease status of the lung habitat governed the adaptation of more strongly than the underlying bacterial clone-type and its genetic repertoire.

摘要

慢性呼吸道感染革兰氏阴性菌是囊性纤维化 (CF) 患者生活质量和预后的重要合并症。这种长期定植,有时可持续数十年,为研究病原体对宿主的适应过程提供了独特的机会。我们的研究旨在确定细菌对 CF 气道的适应是否以及在何种程度上影响病原体在肺部生长和持续存在的适应性。使用鼠类和人类精密切割肺切片 (PCLS) 对通过菌株特异性 SNP 区分的连续分离株进行无标记竞争适应性实验。从六例轻度和六例重度 CF 患者的病程中分别选择连续分离株。将 MPCLS 或 hPCLS 用相同数量的一个病程的连续分离株混合物接种。通过多重标记扩增子测序定量竞争生长过程中细菌群落组成的时间变化。两种模型均显示轻度和重度病程之间的适应性特征存在明显分离。在重度病程中,早期分离株在竞争中占主导地位,而在轻度病程中,中间和晚期分离株通常赢得竞争。CF 肺部疾病的状况而不是细菌基因型驱动 CF 肺部慢性感染期间 的适应。这意味着肺部栖息地的疾病状况比潜在的细菌克隆型及其遗传库更能影响 的适应性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/c81032a3ec9d/fcimb-12-992214-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/f93d1b7da7d9/fcimb-12-992214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/3f7e0ac06ef8/fcimb-12-992214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/a4adedbe1b79/fcimb-12-992214-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/c81032a3ec9d/fcimb-12-992214-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/f93d1b7da7d9/fcimb-12-992214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/3f7e0ac06ef8/fcimb-12-992214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/a4adedbe1b79/fcimb-12-992214-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f1/9446154/c81032a3ec9d/fcimb-12-992214-g004.jpg

相似文献

1
Competitive fitness of isolates in human and murine precision-cut lung slices.在人体和鼠类精密切割肺切片中分离株的竞争适应性。
Front Cell Infect Microbiol. 2022 Aug 23;12:992214. doi: 10.3389/fcimb.2022.992214. eCollection 2022.
2
Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis.从患有囊性纤维化的年轻患者中纵向分离的铜绿假单胞菌的基因组和功能特征。
Microbiol Spectr. 2023 Aug 17;11(4):e0155623. doi: 10.1128/spectrum.01556-23. Epub 2023 Jun 26.
3
Intraclonal competitive fitness of longitudinal cystic fibrosis Pseudomonas aeruginosa airway isolates in liquid cultures.纵向囊性纤维化铜绿假单胞菌气道分离株在液体培养中的克隆内竞争适应性。
Environ Microbiol. 2020 Jul;22(7):2536-2549. doi: 10.1111/1462-2920.14924. Epub 2020 Feb 7.
4
Long-Term Microevolution of Pseudomonas aeruginosa Differs between Mildly and Severely Affected Cystic Fibrosis Lungs.铜绿假单胞菌在轻度和重度囊性纤维化肺部的长期微进化存在差异。
Am J Respir Cell Mol Biol. 2018 Aug;59(2):246-256. doi: 10.1165/rcmb.2017-0356OC.
5
Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.囊性纤维化微环境中铜绿假单胞菌的适应降低了其在多种感染宿主中的毒力。
PLoS One. 2012;7(4):e35648. doi: 10.1371/journal.pone.0035648. Epub 2012 Apr 25.
6
Microevolution of Pseudomonas aeruginosa in the airways of people with cystic fibrosis.铜绿假单胞菌在囊性纤维化患者气道中的微进化。
Curr Opin Immunol. 2023 Aug;83:102328. doi: 10.1016/j.coi.2023.102328. Epub 2023 Apr 26.
7
Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.囊性纤维化肺病患者肺部感染金黄色葡萄球菌分离株的基因表型多样性及其与铜绿假单胞菌的相互作用。
mBio. 2020 Jun 23;11(3):e00735-20. doi: 10.1128/mBio.00735-20.
8
Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.铜绿假单胞菌向囊性纤维化肺部慢性病原体的微进化。
Curr Top Microbiol Immunol. 2013;358:91-118. doi: 10.1007/82_2011_199.
9
Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.铜绿假单胞菌在慢性囊性纤维化肺部感染中的挥发物组特征及适应性
mSphere. 2020 Oct 7;5(5):e00843-20. doi: 10.1128/mSphere.00843-20.
10
Evolutionary Genomics of Niche-Specific Adaptation to the Cystic Fibrosis Lung in Pseudomonas aeruginosa.铜绿假单胞菌对囊性纤维化肺的生态位特异性适应的进化基因组学。
Mol Biol Evol. 2021 Jan 23;38(2):663-675. doi: 10.1093/molbev/msaa226.

引用本文的文献

1
Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report.细菌性肺炎实验模型开发与应用的最佳实践:美国胸科学会官方研讨会报告
Am J Respir Cell Mol Biol. 2025 Aug;73(2):178-199. doi: 10.1165/rcmb.2025-0322ST.
2
Understanding Comorbidities of Respiratory Models as Novel Platforms for Drug Discovery.理解作为药物发现新平台的呼吸系统模型的共病情况。
ACS Pharmacol Transl Sci. 2024 Oct 25;7(11):3385-3393. doi: 10.1021/acsptsci.4c00484. eCollection 2024 Nov 8.
3
Mucin adhesion of serial cystic fibrosis airways isolates.

本文引用的文献

1
Human Multi-Compartment Platform for Emulating Respiratory Airborne Transmission: From Nose to Pulmonary Acini.用于模拟呼吸道空气传播的人体多腔室平台:从鼻腔到肺腺泡
Front Physiol. 2022 Mar 8;13:853317. doi: 10.3389/fphys.2022.853317. eCollection 2022.
2
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections.联合应用 Ivacaftor 和强化抗生素可有限清除囊性纤维化感染。
mBio. 2021 Dec 21;12(6):e0314821. doi: 10.1128/mbio.03148-21. Epub 2021 Dec 14.
3
Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016.
连续囊性纤维化气道分离株的粘蛋白黏附。
Front Cell Infect Microbiol. 2024 Aug 22;14:1448104. doi: 10.3389/fcimb.2024.1448104. eCollection 2024.
4
Amoebae as training grounds for microbial pathogens.变形虫作为微生物病原体的培养基地。
mBio. 2024 Aug 14;15(8):e0082724. doi: 10.1128/mbio.00827-24. Epub 2024 Jul 8.
5
Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery.精准切取肺切片:用于研究肺生理学、药理学、疾病发病机制和药物发现的一体化离体模型。
Respir Res. 2024 Jun 1;25(1):231. doi: 10.1186/s12931-024-02855-6.
6
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy.用于门诊治疗的抗假单胞菌β-内酰胺类药物的稳定性研究
Pharmaceutics. 2023 Nov 30;15(12):2705. doi: 10.3390/pharmaceutics15122705.
7
Competitive survival of clonal serial isolates from cystic fibrosis airways in human neutrophils.囊性纤维化气道克隆性系列分离株在人中性粒细胞中的竞争性存活
iScience. 2023 Mar 24;26(4):106475. doi: 10.1016/j.isci.2023.106475. eCollection 2023 Apr 21.
2010-2016 年美国囊性纤维化中心感染发生率的纵向变化和地域差异。
J Cyst Fibros. 2022 Jan;21(1):34-39. doi: 10.1016/j.jcf.2021.08.009. Epub 2021 Aug 26.
4
Triple Therapy for Cystic Fibrosis -Gating and -Residual Function Genotypes.囊性纤维化-门控和-残留功能基因型的三联疗法。
N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665.
5
Precision cut lung slices: an ex vivo model for assessing the impact of immunomodulatory therapeutics on lung immune responses.精密肺切片:一种用于评估免疫调节疗法对肺部免疫反应影响的离体模型。
Arch Toxicol. 2021 Aug;95(8):2871-2877. doi: 10.1007/s00204-021-03096-y. Epub 2021 Jun 30.
6
Rhinovirus-induced Human Lung Tissue Responses Mimic Chronic Obstructive Pulmonary Disease and Asthma Gene Signatures.鼻病毒诱导的人肺组织反应模拟慢性阻塞性肺疾病和哮喘的基因特征。
Am J Respir Cell Mol Biol. 2021 Nov;65(5):544-554. doi: 10.1165/rcmb.2020-0337OC.
7
Cystic fibrosis.囊性纤维化。
Lancet. 2021 Jun 5;397(10290):2195-2211. doi: 10.1016/S0140-6736(20)32542-3.
8
Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.美国和英国囊性纤维化患儿的肺功能:国家注册数据的比较纵向分析。
Thorax. 2022 Feb;77(2):136-142. doi: 10.1136/thoraxjnl-2021-216849. Epub 2021 May 11.
9
Take my breath away: studying pathogen invasion of the human lung using primary tissue models.令人屏息:使用原代组织模型研究病原体对人肺的侵袭。
Pathog Dis. 2021 Mar 31;79(4). doi: 10.1093/femspd/ftab016.
10
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One Allele.一项评估 elexacaftor/tezacaftor/ivacaftor 在至少携带一个突变等位基因的囊性纤维化 6 至 11 岁儿童中的疗效和安全性的 3 期、开放性标签研究。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1522-1532. doi: 10.1164/rccm.202102-0509OC.